coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    St Helens Central PCN, St. Helens (LAD) · Health Inequalities Profile

    PCN U67149 · NHS Cheshire and Merseyside Integrated Care Board · 8 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    39,055

    Registered population

    60.5% aged 18–64

    21.0%

    Aged 65+

    ICB 19.0% · England 17.9%

    3.6%

    Ethnic minority (non-White)

    1.4% Asian · England 9.6%

    50.6%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~12,383

    Core20 residents (est.)

    Resident basis; registered basis ~22,796 · see page 3

    7,293

    Hypertension register

    +4.31% in 3 yrs · England +5.60%

    420

    SMI register

    18.5% of St. Helens (LAD)'s

    1,309

    COPD register

    Reviews +3.13% in 3 yrs

    Forecast to 2030

    8,178

    Hypertension patients, 2030

    +885 on today

    65.4%

    QRISK ≥20% on statins, 2030

    +2.12pp over 3 yrs

    4.8%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    52.0%
    Cardiovascular and diabetes secondary prevention lags England.

    Non-frail diabetes HbA1c control (52.0% vs England's 57.4%), under-80 BP control (65.2% vs 67.8%) and QRISK ≥ 20% lipid therapy (60.9% vs 63.6%) trail.

    -7.7%
    Learning disability register fell; SMI checks trail.

    Learning disability prevalence fell -7.7% (England +5.4%; +25 to +36 benchmark scenario), while SMI BP (79.1% vs 83.4%) and BMI (75.7% vs 82.1%) checks.

    80.9%
    Heart failure and COPD reviews exceed England.

    Heart failure reviews reached 80.9% (England 78.5%) after +19.8% three-year growth, alongside 80.4% annual review coverage for COPD patients (England 76.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65 and over represent 21.0% of registrations, exceeding England's 17.9%

    ST HELENS CENTRAL PCN cares for 39,055 registered patients, with an older demographic shaping service planning: 21.0% (8,195 patients) are aged 65+, exceeding St. Helens (LAD) at 20.1%, the ICB at 19.0%, and England at 17.9%. Patients aged 0-17 comprise 18.5% (LAD 18.7%, ICB 19.2%, England 19.6%). Census estimates show 96.4% White ethnicity (LAD 96.5%, ICB 93.0%, England 81.1%), with a 3.6% ethnic minority share. Projected list growth to 2030 is 1.8% (LAD 1.6%, ICB 2.3%, England 2.3%), though projection methods are unverified and Census ethnicity reflects catchment residents rather than registered lists.

    Age profile

    0–1718.5%
    18–6460.5%
    65+21.0%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White96.4%
    Asian1.4%
    Mixed1.1%
    Other0.6%
    Black0.5%

    Older people · falls rows are St. Helens (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (St. Helens LA)2,2082,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)77.4%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)52.0%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (St. Helens LA)1,1431,0219552024/25
    Falls deaths, all ages, per 100,000 (St. Helens LA)24.818.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Deprivation spans all practices with Core20 share at 50.6% against England's 21.0%

    ST HELENS CENTRAL PCN has a Core20 share of 50.6%, above St. Helens (LAD) at 38.5%, the ICB at 31.9%, and England at 21.0%. Across practices, Core20 concentration spans a 58.2 pp range, from 41.8% at Marshalls Cross Medical Centre to 100.0% at Parkfield Surgery. Core20 volume peaks at Hall Street Medical Centre (5,078) and Ormskirk House Surgery (4,447). Practice estimates sum to 22,796 registered patients versus 12,383 resident Core20 people. The PCN should adopt dual targeting by concentration and caseload volume once denominators are reconciled.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Parkfield100.0% · 2,592 patients
    Hall Street78.2% · 5,078 patients
    Ormskirk House64.4% · 4,447 patients
    Newholme59.8% · 1,891 patients
    Lingholme53.0% · 1,802 patients
    Phoenix43.1% · 1,414 patients
    Central42.5% · 2,784 patients
    Marshalls Cross41.8% · 2,788 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    420

    SMI register

    1.07% recorded prevalence

    194

    Learning disability register

    0.50% recorded prevalence

    17

    Care homes, 645 beds

    In the PCN catchment

    11.7%

    Provide unpaid care

    St. Helens (LAD), Census 2021

    Registers record 420 patients with severe mental illness (1.1% vs St. Helens (LAD) 1.1%, ICB 1.1%, England 1.0%) and 194 with learning disabilities (0.5% vs St. Helens (LAD) 0.6%, ICB 0.6%, England 0.6%), alongside 17 catchment care homes containing 645 beds (occupancy unmeasured).

    Severe mental illness: physical health checks

    On the SMI register (420 patients), annual checks trail England: blood pressure is 79.1% (England 83.4%), BMI 75.7% (England 82.1%) and alcohol status 74.7% (England 81.8%). Separate outreach is needed to close physical check gaps.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,293

    Hypertension register

    +4.31%

    Register growth, 3 yrs

    St. Helens (LAD) +5.27% · England +5.60%

    +0.83pp

    BP control, under 80

    ≤140/90 · +4.04pp aged 80+

    +885

    More patients by 2030

    Forecast 8,178 (20.28%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 18.6% (7,293 patients), close to St. Helens (LAD) (18.7%) and above the ICB (16.8%) and England (15.2%). Practice prevalence ranges from 14.2% at Marshalls Cross Medical Centre to 23.6% at Parkfield Surgery. While 86.8% of hypertensive patients had a recent blood pressure check (England 90.0%), blood pressure control under age 80 is 65.2%, trailing St. Helens (LAD) (65.9%), the ICB (66.4%) and England (67.8%). Observation periods were not supplied and rates are not age-adjusted. Lower under-80 blood pressure control than across England suggests an opportunity to prioritise systematic medication titration and recall for patients aged under 80.

    Lipids and statins

    For patients with QRISK ≥ 20%, 60.9% receive lipid-lowering therapy, trailing St. Helens (LAD) (62.1%), the ICB (63.2%) and England (63.6%). Adult lipid-regulating prescribing (2026) is 2,173 items per 1,000 versus 4,100 in England. This indicates an opportunity to review lipid-lowering therapy initiation for high-risk patients.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202669,202£1.90£1.71£1.86£131,484
    Cardiovascular (all), 2025116,156£4.54£4.37£3.33£527,348

    In 2026, lipid-regulating drugs cost £1.90 per item across 69,202 items, compared with £1.75 in St. Helens (LAD), £1.71 in the ICB and £1.86 in England, representing £2,768 more than at England's unit cost. This unit-cost indicator does not establish prescribing efficiency or formulary choices.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +5.02%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.48%

    Asthma prevalence, PCN 3-yr % change

    Recorded COPD prevalence is 3.4% (1,309 patients; England 1.9%), rising +7.8% over 2023 to 2025 (England +2.6%), while annual reviews reached 80.4% (England 76.4%). Asthma prevalence is 7.7% (2,850 patients; England 6.6%), but annual reviews reached 65.4% (England 65.7%), leaving an estimated 985 patients unreviewed. Furthermore, asthma prescribing for ages 5-19 is 3,277 items per 1,000 (England 1,488). The modelled shortfall of 985 unreviewed asthma patients coincides with high paediatric prescribing, indicating an area for clinical review.

    Cancer register and children's immunisation

    In Q1 2025/26, cancer register prevalence is 4.0% (1,577 patients; England 3.8%). In childhood immunisations, MMR dose 1 reaches 96.2% at age 5, but dose 2 drops by 11.6 pp to 84.6% (10.4 pp below the 95.0% target). The 4-in-1 booster reaches 82.7% (12.3 pp below target), and MMR1 at 24 months is 85.5% (England 88.3%). Targeted recall is required to reduce preschool booster drop-off.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months94.8%

    England 91.0%

    6-in-1 complete primary course at 24 months90.0%

    England 92.2%

    MMR dose 1 at 24 months85.5%

    England 88.3%

    MMR dose 2 at age 584.6%

    England 82.8%

    4-in-1 pre-school booster at age 582.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    In 2022, 55.5% of cancers with a known stage in NHS Cheshire and Merseyside ICB (7,482 of 13,490) were diagnosed at stage 1 or 2, 19.5 pp below the 75.0% national ambition by 2028 (England 55.3%). Reaching 75.0% requires about 2,640 extra early diagnoses annually across the ICB, where early staging rose +2.6 pp between 2013 and 2022. Staged coverage was 72.8% (13,490 of 18,522). Staging is not available for PCNs. In cervical screening, ST HELENS CENTRAL PCN reached 68.4% (England 66.8%, St. Helens (LAD) 69.2%), while Phoenix Medical Centre recorded 60.7% and Newholme Surgery recorded 63.4%.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For Mersey and West Lancashire Teaching Hospitals NHS Trust, performance on the 62-day referral to treatment standard fell below the 85.0% standard by 7.0 pp, while NHS Cheshire and Merseyside Integrated Care Board trailed by 8.8 pp. On the 28-day faster diagnosis standard, the trust was 2.6 pp below the 75.0% target, whereas the ICB exceeded it by 2.2 pp. On the 31-day combined treatment standard, the trust was 0.5 pp below the 96.0% standard, with the ICB trailing by 0.3 pp. These waiting standards describe trust and ICB pathways rather than PCN performance.

    Pathways within standard (%)Mersey and West LancashireNorth Cheshire and MerseyLiverpoolCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)72.3980.2175.4777.2579.32
    31-day treatment (96%)95.4698.1790.5195.7192.50
    62-day referral to treatment (85%)77.9683.6773.2676.2371.16
    Diagnostic waits over 6 weeks (%)Mersey and West LancashireNorth Cheshire and MerseyLiverpoolEngland
    MRI14.040.536.4221.40
    CT13.082.320.719.92
    Echocardiography34.8828.0412.5528.48
    Colonoscopy18.0415.9833.1430.83
    Gastroscopy18.1720.2444.9929.02
    All 15 DM01 tests21.176.3411.5023.14
    Community services activitySt. Helens residentsCheshire and Merseyside ICB
    Care contacts48,525541,280
    Referrals7,81597,150
    Patients with a contact12,745146,240

    Community services (residents of St. Helens), Jun 2026 (provisional). In Jun 2026 (provisional), community contacts for St. Helens borough residents aged 65 and over reached 29,090 of 48,525 total contacts, representing a 59.9% share. These community service figures describe borough resident activity rather than PCN-level delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access varies by 45.3 pp across practices, spanning 42.6% to 87.9%

    Overall QOF achievement ranges from 67.6% at Central Surgery to 95.5% at Phoenix Medical Centre against England's 92.5%. Vaccination and immunisation achievement varies across practices by 75.6 pp, from 15.6% at Ormskirk House Surgery to 91.2% at Phoenix Medical Centre (England 55.2%). Published domain points reflect points awarded rather than direct patient coverage.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Hall Street9378.287.5%72.5%95.2%
    Parkfield Surgery103100.084.1%80.6%93.1%
    Lingholme9853.087.9%80.8%90.5%
    Ormskirk House11364.478.8%87.8%88.3%
    Newholme Surgery9259.887.2%67.7%84.5%
    Phoenix11443.156.8%86.7%79.2%
    Marshalls Cross10641.842.6%70.1%78.1%
    Central Surgery10942.570.8%51.6%77.7%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNSt. Helens (LAD)AssetPCNSt. Helens (LAD)
    Care homes (catchment)17 (645 beds)n/aSchools (catchment)59n/a
    Children's centres48Places of worship4090
    Libraries715Primary schools (LA maintained)1732
    Primary academies311Special schools12

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Cardiovascular and diabetes secondary prevention review

    Under-80 BP control is 65.2% (England 67.8%), QRISK ≥ 20% lipid therapy is 60.9% (England 63.6%), and non-frail diabetes HbA1c ≤ 58 mmol/mol is 52.0% (1,175 of 2,259; England 57.4%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Asthma annual review and prescribing recall

    Asthma review coverage is 65.4% (England 65.7%, St. Helens (LAD) 58.2%) across 2,850 patients (985 estimated unreviewed); ages 5-19 prescribing is 3,277 items per 1,000 (England 1,488). For discussion: practices could align asthma recall with repeat inhaler prescribing reviews and offer flexible after-school clinic slots for children. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Learning disability register coding validation

    Learning disability QOF prevalence is 0.5% (194 patients) versus 0.6% in St. Helens (LAD), ICB and England (range +25 to +36), changing -7.7% over 2023 to 2025 (England +5.4%). For discussion: audit learning disability clinical coding and cross-check registers against local authority social-care records where data-sharing agreements exist. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Systematic SMI physical health outreach (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension blood pressure control audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool booster recall outreach (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall outreach (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Practice telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Cardiovascular and diabetes secondary prevention review (p12)Hypertension register · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) · Patients with QRISK ≥ 20% treated with lipid lowering therapyCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · Asthma annual review and prescribing recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Asthma management items prescribed per 1000 5-19 PopulationCore20PLUS5 respiratoryPCN
    Option 3 · Learning disability register coding validation (p12)Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15